Literature DB >> 8648093

Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase.

J Sen1, R Kapeller, R Fragoso, R Sen, L I Zon, S J Burakoff.   

Abstract

Thymocytes develop into mature functional T cells in the inductive environment of the thymus where thymocyte-stromal cell interactions and cytokines provide survival and differentiation signals as cues for thymocyte maturation. Disruption of the thymic microenvironment results in attenuation of T cell maturation, suggesting that intrathymic signals are essential for differentiation and repertoire selection. We have previously shown that several inducible nuclear factors such as AP-1, NF-AT, and NF-kappaB are activated in response to intrathymic signals. Here we demonstrate that in thymocytes p38 mitogen-activated protein (MAP) kinase, a member of the MAP kinase family of proteins that include the extracellular-signal regulated kinases and Jun aminoterminal kinases, is highly activated in response to intrathymic signals in vivo. These studies suggest a role for p38 MAP kinase in T cell survival and differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648093

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.

Authors:  M Rincón; H Enslen; J Raingeaud; M Recht; T Zapton; M S Su; L A Penix; R J Davis; R A Flavell
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

2.  The critical role of p38 MAP kinase in T cell HIV-1 replication.

Authors:  P S Cohen; H Schmidtmayerova; J Dennis; L Dubrovsky; B Sherry; H Wang; M Bukrinsky; K J Tracey
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

3.  The calcium-independent protein kinase C participates in an early process of CD3/CD28-mediated induction of thymocyte apoptosis.

Authors:  A Asada; Y Zhao; H Komano; T Kuwata; M Mukai; K Fujita; Y Tozawa; R Iseki; H Tian; K Sato; Y Motegi; R Suzuki; M Yokoyama; M Iwata
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

4.  Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice.

Authors:  H T Lu; D D Yang; M Wysk; E Gatti; I Mellman; R J Davis; R A Flavell
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  Generation and characterization of p38beta (MAPK11) gene-targeted mice.

Authors:  Victoria A Beardmore; Heather J Hinton; Christina Eftychi; Maria Apostolaki; Maria Armaka; Joanne Darragh; Joanne McIlrath; Julia M Carr; Laura J Armit; Carol Clacher; Loraine Malone; George Kollias; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

6.  Alternative ZAP70-p38 signals prime a classical p38 pathway through LAT and SOS to support regulatory T cell differentiation.

Authors:  Jesse E Jun; Kayla R Kulhanek; Hang Chen; Arup Chakraborty; Jeroen P Roose
Journal:  Sci Signal       Date:  2019-07-23       Impact factor: 8.192

7.  Nuclear localization of p38 MAPK in response to DNA damage.

Authors:  C David Wood; Tina M Thornton; Guadalupe Sabio; Roger A Davis; Mercedes Rincon
Journal:  Int J Biol Sci       Date:  2009-06-16       Impact factor: 6.580

8.  Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation.

Authors:  Marisa M Juntilla; Jessica A Wofford; Morris J Birnbaum; Jeffrey C Rathmell; Gary A Koretzky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

9.  Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo.

Authors:  N L Diehl; H Enslen; K A Fortner; C Merritt; N Stetson; C Charland; R A Flavell; R J Davis; M Rincón
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

10.  The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes.

Authors:  M Rincón; A Whitmarsh; D D Yang; L Weiss; B Dérijard; P Jayaraj; R J Davis; R A Flavell
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.